DDX41 Mutations in Myeloid Neoplasms Are Associated with Male Predominance, TP53 mutation and a High Risk of Progression to AML

被引：0
|
作者：
Quesada, Andres E. [1 ]
DiNardo, Courtney [1 ]
Routbort, Mark
Bueso-Ramos, Carlos [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Zuo, Zhuang [1 ]
Yin, C. Cameron [1 ]
Loghavi, Sanam
Ok, Chi Young [1 ]
Wang, Sa [1 ]
Benton, Christopher [1 ]
Kantarjian, Hagop M. [1 ]
Luthra, Rajyalakshmi [1 ]
Medeiros, L. Jeffrey [1 ]
Patel, Keyur [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Bellaire, TX USA
[3] UT MD Anderson Canc Ctr, Sugar Land, TX USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1530
引用
收藏
页码：545 / 545
页数：1
相关论文
共 50 条
  • [21] Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
    Makishima, Hideki
    Saiki, Ryunosuke
    Nannya, Yasuhito
    Korotev, Sophia
    Gurnari, Carmelo
    Takeda, June
    Momozawa, Yukihide
    Best, Steve
    Krishnamurthy, Pramila
    Yoshizato, Tetsuichi
    Atsuta, Yoshiko
    Shiozawa, Yusuke
    Iijima-Yamashita, Yuka
    Yoshida, Kenichi
    Shiraishi, Yuichi
    Nagata, Yasunobu
    Kakiuchi, Nobuyuki
    Onizuka, Makoto
    Chiba, Kenichi
    Tanaka, Hiroko
    Kon, Ayana
    Ochi, Yotaro
    Nakagawa, Masahiro M.
    Okuda, Rurika
    Mori, Takuto
    Yoda, Akinori
    Itonaga, Hidehiro
    Miyazaki, Yasushi
    Sanada, Masashi
    Ishikawa, Takayuki
    Chiba, Shigeru
    Tsurumi, Hisashi
    Kasahara, Senji
    Mueller-Tidow, Carsten
    Takaori-Kondo, Akifumi
    Ohyashiki, Kazuma
    Kiguchi, Toru
    Matsuda, Fumihiko
    Jansen, Joop H.
    Polprasert, Chantana
    Blombery, Piers
    Kamatani, Yoichiro
    Miyano, Sator
    Malcovati, Luca
    Haferlach, Torsten
    Kubo, Michiaki
    Cazzola, Mario
    Kulasekararaj, Austin G.
    Godley, Lucy A.
    Maclejewski, Jaroslaw P.
    BLOOD, 2023, 141 (05) : 534 - 549
  • [22] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    LABORATORY INVESTIGATION, 2018, 98 : 524 - 525
  • [23] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    MODERN PATHOLOGY, 2018, 31 : 524 - 525
  • [24] Impact of Somatic Second Hit and Comutations in Myeloid Neoplasms with Germline DDX41 Mutations
    Sapinho, Guilherme Mendes
    Krishnamurthy, Pramila
    Hannah, Guy
    Gandhi, Shreyans
    Potter, Victoria
    Shah, Mili
    Lea, Nicholas
    Engelbrecht, Clair
    Bezuidenhout, Heidre
    Snape, Katie
    Best, Steve
    Kulasekararaj, Austin
    BLOOD, 2023, 142
  • [25] Characterization of TP53 Mutations in Myeloid Neoplasms for Targeted Therapy
    Romero, A. Mindiola
    Loo, E.
    Green, D.
    Houde, B.
    Deharvengt, S.
    Tsongalis, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S19 - S19
  • [26] Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 Mutation
    Nelles, Ricky
    Butler, Jason
    Curley, Cameron
    Henden, Andrea S.
    Hunt, Stewart
    Morton, James
    Subramoniapillai, Elango
    Stewart, Caroline
    Tey, Siok-Keen
    Kennedy, Glen A.
    Scott, Ashleigh P.
    BLOOD, 2024, 144 : 7439 - 7440
  • [27] IMPACT OF ALLELIC STATUS OF TP53 MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML)
    Ibanez, Mariam
    Barragan, Eva
    Roson-Burgo, Beatriz
    Such, Esperanza
    Avetisya, Gayane
    Mora, Elvira
    Liquori, Alessandro
    Sargas, Claudia
    Llop, Marta
    Senent, Leonor
    Vicente, Ana
    Luna, Irene
    Sempere, Amparo
    Andreu, Rafa
    Montesinos, Pau
    Cervera, Jose
    Sanz, Guillermo
    HAEMATOLOGICA, 2020, 105 : 5 - 6
  • [28] TP53 mutation screening for patients at risk of myeloid malignancy
    Mukherjee, Devdeep
    Lawal, Rialnat A.
    Fitzhugh, Courtney D.
    Hourigan, Christopher S.
    Dillon, Laura W.
    LEUKEMIA, 2024, 38 (07) : 1604 - 1608
  • [29] GENETIC PREDISPOSITIONS TO SPORADIC MYELOID NEOPLASMS CAUSED BY GERMLINE DDX41 MUTATIONS IN ASIAN AND CAUCASIAN POPULATIONS.
    Takeda, J.
    Yoshida, K.
    Makishima, H.
    Yoshizato, T.
    Shiozawa, Y.
    Suzuki, H.
    Shiraishi, Y.
    Okuno, Y.
    Kon, A.
    Kataoka, K.
    Chiba, K.
    Tanaka, H.
    Sanada, M.
    Sakata-Yanagimoto, M.
    Obara, N.
    Nakamaki, T.
    Ishiyama, K.
    Hangaishi, A.
    Chiba, S.
    Mori, H.
    Asou, N.
    Kiyoi, H.
    Hirase, C.
    Imai, K.
    Dobashi, N.
    Kiguchi, T.
    Miyazaki, Y.
    Naoe, T.
    Miyano, S.
    Usuki, K.
    Miyawaki, S.
    Kamatani, Y.
    Momozawa, Y.
    Kubo, M.
    Suzuki, Y.
    Kawai, Y.
    Nagasaki, M.
    Sekeres, M. A.
    Polprasert, C.
    Maciejewski, J. P.
    Ogawa, S.
    HAEMATOLOGICA, 2016, 101 : 66 - 67
  • [30] Clinical and Molecular Characteristics of Acute Myeloid Leukemia (AML) Patients with TP53 Mutations and TP73 Mutations
    Mims, Alice S.
    Kohlschmidt, Jessica
    Eisfeld, Ann-Kathrin
    Mrozek, Krzysztof
    Blachly, James S.
    Orwick, Shelley
    Papaioannou, Dimitrios
    Nicolet, Deedra
    Sampath, Deepa
    Stone, Richard M.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Byrd, John C.
    Bloomfield, Clara D.
    BLOOD, 2018, 132
12345